Literature DB >> 11601684

Reference intervals and variation for urinary epinephrine, norepinephrine and cortisol in healthy men and women in Denmark.

A M Hansen1, A H Garde, J M Christensen, N H Eller, B Netterstrøm.   

Abstract

Reference intervals for urinary epinephrine, norepinephrine and cortisol in 120 healthy individuals performing their routine work were established according to the International Union of Pure and Applied Chemistry (IUPAC) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) for use in the risk assessment of exposure to occupational stress. Reference intervals were established for three different times of the day: in morning samples (05.45-07.15) the limit of detection (LOD) was 2.10 micromol epinephrine/mol creatinine (82 women) and 2.86 micromol epinephrine/mol creatinine (37 men), and the reference interval was 3.6-29.1 micromol norepinephrine/mol creatinine and 2.3-52.8 micromol cortisol/mol creatinine (119 women and men); in afternoon samples (15.30-18.30) the reference interval was 0.64-10.8 micromol epinephrine/mol creatinine (82 women), 1.20-11.2 micromol/epinephrine/mol creatinine (36 men), 11.0-54.1 micromol/ norepinephrine/mol creatinine and LOD was 42.4 micromol cortisol/mol creatinine (117 women and men); in evening samples (21.45-23.45) LOD was 8.66 micromol epinephrine/mol creatinine (81 women) and 7.99 micromol/epinephrine/mol creatinine (36 men), the reference interval was 11.0-54.1 micromol norepinephrine/mol creatinine, and LOD was 42.4 micromol cortisol/mol creatinine (117 women and men). A variance component model for describing the effects of age, body mass index (BMI), diurnal variation, gender, days of sick leave during past year and smoking habits was established. Women showed a higher morning value but excreted lower amounts of epinephrine during the day as compared to men. No gender differences could be demonstrated for the excretion of norepinephrine and cortisol. Excretion of epinephrine and norepinephrine increased with smoking and decreased with increased BMI. No effects were observed in the excretion of cortisol.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11601684     DOI: 10.1515/CCLM.2001.140

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  6 in total

1.  A cross-sectional study evaluating the relationship between cortisol suppression and asthma control in patients with difficult asthma.

Authors:  S Aburuz; L G Heaney; J Millership; J Gamble; J McElnay
Journal:  Br J Clin Pharmacol       Date:  2007-01       Impact factor: 4.335

2.  Urinary Metabolomic Study in a Healthy Children Population and Metabolic Biomarker Discovery of Attention-Deficit/Hyperactivity Disorder (ADHD).

Authors:  Xiaoyi Tian; Xiaoyan Liu; Yan Wang; Ying Liu; Jie Ma; Haidan Sun; Jing Li; Xiaoyue Tang; Zhengguang Guo; Wei Sun; Jishui Zhang; Wenqi Song
Journal:  Front Psychiatry       Date:  2022-05-20       Impact factor: 5.435

3.  Neurally mediated syncope: Is it really an endothelial dysfunction?

Authors:  Bahar Dehghan; Mohammad Reza Sabri; Shaghayegh Haghjooy Javanmard; Ali Reza Ahmadi; Marjan Mansourian
Journal:  Anatol J Cardiol       Date:  2015-07-29       Impact factor: 1.596

4.  Predictors of plasma and urinary catecholamine levels in normotensive and hypertensive men and women.

Authors:  A R Saxena; B Chamarthi; G H Williams; P N Hopkins; E W Seely
Journal:  J Hum Hypertens       Date:  2013-11-14       Impact factor: 3.012

5.  Morning vaccination enhances antibody response over afternoon vaccination: A cluster-randomised trial.

Authors:  Joanna E Long; Mark T Drayson; Angela E Taylor; Kai M Toellner; Janet M Lord; Anna C Phillips
Journal:  Vaccine       Date:  2016-04-26       Impact factor: 3.641

6.  Sex difference in sympathetic nervous system activity and blood pressure in hypertensive patients.

Authors:  Chin-Chou Huang; Chia-Min Chung; Hsin-Bang Leu; Po-Hsun Huang; Tao-Cheng Wu; Liang-Yu Lin; Shing-Jong Lin; Wen-Harn Pan; Jaw-Wen Chen
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-11-15       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.